{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:22:49Z","timestamp":1788481369688,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Research Project of Yangzhou Municipal Health Commission","award":["2023-2-23"],"award-info":[{"award-number":["2023-2-23"]}]},{"name":"Beijing Medical Award Foundation","award":["YXJL-2024-0299-0065"],"award-info":[{"award-number":["YXJL-2024-0299-0065"]}]},{"name":"Yangzhou Basic Research Program","award":["2024-2-23"],"award-info":[{"award-number":["2024-2-23"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04629-6","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T03:29:05Z","timestamp":1751599745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ring-finger protein RNF126 promotes prostate cancer progression via regulation of MBNL1"],"prefix":"10.1038","volume":"15","author":[{"given":"Xin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"issue":"1","key":"4629_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12935-022-02546-6","volume":"22","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway. Cancer Cell. Int. 22 (1), 127 (2022).","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"4629_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12935-022-02637-4","volume":"22","author":"C Yu","year":"2022","unstructured":"Yu, C., Fan, Y., Zhang, Y., Liu, L. & Guo, G. LINC00893 inhibits the progression of prostate cancer through miR-3173-5p\/SOCS3\/JAK2\/STAT3 pathway. Cancer Cell. Int. 22 (1), 228 (2022).","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"4629_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12935-021-01934-8","volume":"21","author":"Q Chen","year":"2021","unstructured":"Chen, Q., Fu, L., Hu, J., Guo, G. & Xie, A. Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration. Cancer Cell. Int. 21 (1), 235 (2021).","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"4629_CR4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/14756366.2021.2018684","volume":"37","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells. J. Enzyme Inhib. Med. Chem. 37 (1), 542\u2013553 (2022).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1\u20132","key":"4629_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2014.04.001","volume":"17","author":"A Ganju","year":"2014","unstructured":"Ganju, A. et al. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist. Updat. 17 (1\u20132), 13\u201323 (2014).","journal-title":"Drug Resist. Updat"},{"key":"4629_CR6","doi-asserted-by":"publisher","first-page":"104748","DOI":"10.1016\/j.phrs.2020.104748","volume":"155","author":"R Zhang","year":"2020","unstructured":"Zhang, R., Liu, W., Sun, J., Kong, Y. & Chen, C. Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy. Pharmacol. Res. 155, 104748 (2020).","journal-title":"Pharmacol. Res."},{"key":"4629_CR7","doi-asserted-by":"publisher","first-page":"16019","DOI":"10.1038\/celldisc.2016.19","volume":"2","author":"S Yoshino","year":"2016","unstructured":"Yoshino, S. et al. The ERK signaling target RNF126 regulates Anoikis resistance in cancer cells by changing the mitochondrial metabolic flux. Cell. Discov. 2, 16019 (2016).","journal-title":"Cell. Discov"},{"issue":"5","key":"4629_CR8","doi-asserted-by":"publisher","first-page":"e2203884","DOI":"10.1002\/advs.202203884","volume":"10","author":"W Liu","year":"2023","unstructured":"Liu, W. et al. RNF126-Mediated MRE11 ubiquitination activates the DNA damage response and confers resistance of Triple-Negative breast Cancer to radiotherapy. Adv. Sci. (Weinh). 10 (5), e2203884 (2023).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"11","key":"4629_CR9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/onc.2015.198","volume":"35","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression. Oncogene 35 (11), 1363\u20131372 (2016).","journal-title":"Oncogene"},{"issue":"7\u20138","key":"4629_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s10495-022-01738-9","volume":"27","author":"C Yu","year":"2022","unstructured":"Yu, C., Xue, B., Li, J. & Zhang, Q. Tumor cell-derived exosome RNF126 affects the immune microenvironment and promotes nasopharyngeal carcinoma progression by regulating PTEN ubiquitination. Apoptosis 27 (7\u20138), 590\u2013605 (2022).","journal-title":"Apoptosis"},{"issue":"2","key":"4629_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ijrobp.2021.09.025","volume":"112","author":"P Fa","year":"2022","unstructured":"Fa, P., Qiu, Z., Wang, Q. E., Yan, C. & Zhang, J. A novel role for RNF126 in the promotion of G2 arrest via interaction with 14-3-3sigma. Int. J. Radiat. Oncol. Biol. Phys. 112 (2), 542\u2013553 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"4629_CR12","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1158\/1078-0432.CCR-17-2242","volume":"24","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. RNF126 as a biomarker of a poor prognosis in invasive breast Cancer and CHEK1 inhibitor efficacy in breast Cancer cells. Clin. Cancer Res. 24 (7), 1629\u20131643 (2018).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"4629_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1158\/0008-5472.CAN-12-0562","volume":"73","author":"X Zhi","year":"2013","unstructured":"Zhi, X. et al. E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation. Cancer Res. 73 (1), 385\u2013394 (2013).","journal-title":"Cancer Res."},{"issue":"3","key":"4629_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41419-021-03521-1","volume":"12","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability. Cell. Death Dis. 12 (3), 239 (2021).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"4629_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ng803","volume":"30","author":"D Brett","year":"2002","unstructured":"Brett, D., Pospisil, H., Valcarcel, J., Reich, J. & Bork, P. Alternative splicing and genome complexity. Nat. Genet. 30 (1), 29\u201330 (2002).","journal-title":"Nat. Genet."},{"issue":"4","key":"4629_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1182\/blood-2013-12-542209","volume":"124","author":"AW Cheng","year":"2014","unstructured":"Cheng, A. W. et al. Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis. Blood 124 (4), 598\u2013610 (2014).","journal-title":"Blood"},{"issue":"2","key":"4629_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.molcel.2014.08.027","volume":"56","author":"R Batra","year":"2014","unstructured":"Batra, R. et al. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol. Cell. 56 (2), 311\u2013322 (2014).","journal-title":"Mol. Cell."},{"issue":"4","key":"4629_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cell.2012.06.041","volume":"150","author":"ET Wang","year":"2012","unstructured":"Wang, E. T. et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 150 (4), 710\u2013724 (2012).","journal-title":"Cell"},{"issue":"3","key":"4629_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.stem.2022.01.012","volume":"29","author":"D Bugg","year":"2022","unstructured":"Bugg, D. et al. MBNL1 drives dynamic transitions between fibroblasts and myofibroblasts in cardiac wound healing. Cell. Stem Cell. 29 (3), 419\u2013433e410 (2022).","journal-title":"Cell. Stem Cell."},{"issue":"11","key":"4629_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-018-0085-0","volume":"15","author":"A Paschalis","year":"2018","unstructured":"Paschalis, A. et al. Alternative splicing in prostate cancer. Nat. Rev. Clin. Oncol. 15 (11), 663\u2013675 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"4629_CR21","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/s41467-020-15733-8","volume":"11","author":"SS Itskovich","year":"2020","unstructured":"Itskovich, S. S. et al. MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia. Nat. Commun. 11 (1), 2369 (2020).","journal-title":"Nat. Commun."},{"issue":"21","key":"4629_CR22","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1158\/0008-5472.CAN-20-1233","volume":"80","author":"DM Voss","year":"2020","unstructured":"Voss, D. M., Sloan, A., Spina, R., Ames, H. M. & Bar, E. E. The alternative splicing factor, MBNL1, inhibits glioblastoma tumor initiation and progression by reducing Hypoxia-Induced stemness. Cancer Res. 80 (21), 4681\u20134692 (2020).","journal-title":"Cancer Res."},{"issue":"4","key":"4629_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1101\/gad.270645.115","volume":"30","author":"L Fish","year":"2016","unstructured":"Fish, L. et al. Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts. Genes Dev. 30 (4), 386\u2013398 (2016).","journal-title":"Genes Dev."},{"issue":"3","key":"4629_CR24","first-page":"955","volume":"54","author":"L Tang","year":"2019","unstructured":"Tang, L., Zhao, P. & Kong, D. Muscleblind\u2013like 1 destabilizes snail mRNA and suppresses the metastasis of colorectal cancer cells via the snail\/E\u2013cadherin axis. Int. J. Oncol. 54 (3), 955\u2013965 (2019).","journal-title":"Int. J. Oncol."},{"issue":"8","key":"4629_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nrurol.2011.85","volume":"8","author":"JT Nauseef","year":"2011","unstructured":"Nauseef, J. T. & Henry, M. D. Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle? Nat. Rev. Urol. 8 (8), 428\u2013439 (2011).","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"4629_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41392-021-00788-w","volume":"6","author":"C Xue","year":"2021","unstructured":"Xue, C., Li, G., Lu, J. & Li, L. Crosstalk between circrnas and the PI3K\/AKT signaling pathway in cancer progression. Signal. Transduct. Target. Ther. 6 (1), 400 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"4629_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","volume":"85","author":"R Ullah","year":"2022","unstructured":"Ullah, R., Yin, Q., Snell, A. H. & Wan, L. RAF-MEK-ERK pathway in cancer evolution and treatment. Semin Cancer Biol. 85, 123\u2013154 (2022).","journal-title":"Semin Cancer Biol."},{"issue":"1","key":"4629_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13046-022-02513-z","volume":"41","author":"H Li","year":"2022","unstructured":"Li, H. et al. STAT3\/miR-130b-3p\/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth. J. Exp. Clin. Cancer Res. 41 (1), 297 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"4629_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.7150\/ijbs.41686","volume":"16","author":"X Lu","year":"2020","unstructured":"Lu, X. et al. Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K\/Akt signaling pathways. Int. J. Biol. Sci. 16 (7), 1121\u20131134 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"4629_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","volume":"70","author":"MY Teo","year":"2019","unstructured":"Teo, M. Y., Rathkopf, D. E. & Kantoff, P. Treatment of advanced prostate Cancer. Annu. Rev. Med. 70, 479\u2013499 (2019).","journal-title":"Annu. Rev. Med."},{"key":"4629_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.canlet.2021.09.037","volume":"524","author":"FC Cackowski","year":"2022","unstructured":"Cackowski, F. C. & Heath, E. I. Prostate cancer dormancy and recurrence. Cancer Lett. 524, 103\u2013108 (2022).","journal-title":"Cancer Lett."},{"key":"4629_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2021.06.010","volume":"519","author":"Y Yamada","year":"2021","unstructured":"Yamada, Y. & Beltran, H. The treatment landscape of metastatic prostate cancer. Cancer Lett. 519, 20\u201329 (2021).","journal-title":"Cancer Lett."},{"key":"4629_CR33","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.drup.2019.100663","volume":"48","author":"S Narayanan","year":"2020","unstructured":"Narayanan, S. et al. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance. Drug Resist. Updat. 48, 100663 (2020).","journal-title":"Drug Resist. Updat"},{"issue":"1","key":"4629_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0092-8674(94)90396-4","volume":"79","author":"A Ciechanover","year":"1994","unstructured":"Ciechanover, A. The ubiquitin-proteasome proteolytic pathway. Cell 79 (1), 13\u201321 (1994).","journal-title":"Cell"},{"issue":"2","key":"4629_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrc.2017.105","volume":"18","author":"D Senft","year":"2018","unstructured":"Senft, D., Qi, J. & Ronai, Z. A. Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat. Rev. Cancer. 18 (2), 69\u201388 (2018).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"4629_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41392-022-01152-2","volume":"7","author":"C Cai","year":"2022","unstructured":"Cai, C., Tang, Y. D., Zhai, J. & Zheng, C. The RING finger protein family in health and disease. Signal. Transduct. Target. Ther. 7 (1), 300 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"4629_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1158\/0008-5472.CAN-20-1871","volume":"81","author":"SP Kolapalli","year":"2021","unstructured":"Kolapalli, S. P. et al. RNA-Binding RING E3-Ligase DZIP3\/hRUL138 stabilizes Cyclin D1 to drive Cell-Cycle and Cancer progression. Cancer Res. 81 (2), 315\u2013331 (2021).","journal-title":"Cancer Res."},{"issue":"8","key":"4629_CR38","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1002\/cam4.771","volume":"5","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. E3 ubiquitin ligase RNF126 regulates the progression of tongue cancer. Cancer Med. 5 (8), 2043\u20132047 (2016).","journal-title":"Cancer Med."},{"issue":"28","key":"4629_CR39","doi-asserted-by":"publisher","first-page":"16391","DOI":"10.1073\/pnas.2002499117","volume":"117","author":"D Ray","year":"2020","unstructured":"Ray, D. et al. A tumor-associated splice-isoform of MAP2K7 drives dedifferentiation in MBNL1-low cancers via JNK activation. Proc. Natl. Acad. Sci. U S A. 117 (28), 16391\u201316400 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"9","key":"4629_CR40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41419-022-05219-4","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. The MBNL1\/circNTRK2\/PAX5 pathway regulates aerobic Glycolysis in glioblastoma cells by encoding a novel protein NTRK2-243aa. Cell. Death Dis. 13 (9), 767 (2022).","journal-title":"Cell. Death Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04629-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04629-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04629-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T03:29:05Z","timestamp":1751599745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04629-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4629"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04629-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of Baoying People\u2019s Hospital (BYRY20221202).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"23847"}}